Possible Neuroprotective Strategies for Huntingtons Disease
Journal:
Current Neuropharmacology
Volume:
2
Page:
331-342
Author(s):
James G. Greene
Genetic Studies in Relation to Kuru: An Overview
Journal:
Current Molecular Medicine
Volume:
4
Page:
375-384
Author(s):
L. G. Goldfarb, L. Cervenakova and D. C. Gajdusek
Programmed Axon Death, Synaptic Dysfunction and the Ubiquitin Proteasome System
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
227-238
Author(s):
M. P. Coleman and R. R. Ribchester
Molecular Mechanisms, Proteinopathies and Therapeutic Strategies in Neurodegenerative Disorders
Journal:
Current Genomics
Volume:
5
Page:
327-346
Author(s):
L. K. Sengupta and S. Sengupta
The p35 Family of Apoptosis Inhibitors
Journal:
Current Genomics
Volume:
5
Page:
215-229
Author(s):
A. M. Jabbour and C. J. Hawkins
Involvement of Advanced Glycation End-products (AGEs) in Alzheimers Disease
Journal:
Current Alzheimer Research
Volume:
1
Page:
39-46
Author(s):
Masayoshi Takeuchi, Seiji Kikuchi, Nobuyuki Sasaki, Takako Suzuki, Takayuki Watai, Mina Iwaki, Richard Bucala and Sho-ichi Yamagishi
Protein Misfolding in Disease: Cause or Response?
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
3
Page:
371-383
Author(s):
David R. Howlett
From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy
Journal:
Current Gene Therapy
Volume:
3
Page:
281-304
Author(s):
D. Grimm and M. A. Kay
The Hereditary Disease Array Group (HDAG) - Microarrays, Models and Mechanisms : A Collaboration Update
Journal:
Current Genomics
Volume:
2
Page:
221-229
Author(s):
Tim- Rasmus Kiehl, James M. Olson and Stefan M. Pulst
Expanding our Understanding of Polyglutamine Disease Through Transgenic Mice
Journal:
Current Genomics
Volume:
2
Page:
27-39
Author(s):
Jennifer D. Davidson and Harry T. Orr